Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Nucleic acid ligands against important targets in infectious, malignant and vascular diseases are continually being discovered by the process of in vitro evolution. Promising methods are being developed for the exploitation of these aptamers in biosensors and other diagnostic devices. Ribosome and mRNA display methods for isolating polypeptide aptamers from highly complex libraries have been developed and have the potential to widen the target range and utility of in vitro evolved ligands.


Journal article


Curr Opin Pharmacol

Publication Date





540 - 546


Animals, Combinatorial Chemistry Techniques, Humans, Ligands, Peptide Nucleic Acids